Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (12221)	7/3/2004 1:09:56 PM
From: quidditch	Respond to of 52153

Peter, Thanks. I scanned many and read a handful of the posters and abstracts. The scope and depth of analytical approaches to AD research are truly breathtaking, confounding and humbling. I would hardly have noticed: <<News Embargo: All information contained here is embargoed for release until the date and time of presentation at the Conference, unless written notice of change of date/time is provided in advance by the Alzheimer's Association....>> had the embargo issue not been pointed out. It appears in small print in an obscure part of the screen. quid

To: Biomaven who wrote (12221)	7/5/2004 11:38:34 AM
From: Sam Citron	Respond to of 52153

arguably because anyone can access the material it should be regarded as public That is one argument, Peter, but I would rather err on the side of caution on the issue of trading on "embargoed" information. The prohibition on press coverage could very well be interpreted by a court as preventing the broad dissemination and public access that would be required under the Securities Exchange Act of 1934 to achieve adequate disclosure. Non-public information is information that has not been disclosed to the general public by means of a press release, SEC filing or other medium that ensures broad dissemination and public access. One might certainly argue that internet publication that circumvents or prevents the press from coverage might achieve "broad dissemination and public access", but I am not sure I'd want to be the test case. just my humble non-legal opinion, Sam